1. All Participating NSABP Investigators and Bernard Fisher, Breast Cancer Studies of the NSABP. Abstract — 3rd Int Conf Adj Therapy Cancer, Tucson/Arizona, 1981.
2. Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R: Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep 63:1271 (1979).
3. Allen H, Brooks R, Chase E, Jones S, Heusinkveld R, Giordano GF, Ketchel S, Jackson R, Davis S, Moon T, SalmonS: Adjuvant treatment of node positive breast cancer with adriamycin-cyclophosphamide (AC) ± radiation therapy (XRT). Abstract — 3rd Int Conf Adj Therapy Cancer, Tucson/ Arizona 1981.
4. Bishop HM, Blarney RW, Elston CW, Haybittle JL: Relationship of oestrogen-receptor status to survival in breast cancer. Lancet II: 283 (1979).
5. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, DeLena M, Tancini G, Bajetta E, Musumeci R, Veronesi V: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294:405 (1976).